Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 3270 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 12/09/22
End: 06/15/23
Due: 06/15/24
Phase: N/A
Priority: Normal
Start: 01/25/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 10/04/18
End: 03/01/23
Due: 03/01/24
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 07/11/17
End: 12/11/18
Due: 12/11/19
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 04/13/15
End: 05/31/18
Due: 05/31/19
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 09/10/19
End: 12/10/22
Due: 12/10/23
Phase: N/A
Priority: Normal
Start: 09/30/17
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 07/31/20
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 06/10/21
End: 12/10/23
Due: 12/10/24
Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 10/10/26
Due: 10/10/27
Phase: N/A
Priority: Normal
Start: 05/16/22
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 10/02/21
End: 11/02/23
Due: 11/02/24
Phase: N/A
Priority: Normal
Start: 11/23/20
End: 11/23/21
Due: 11/23/22
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 10/20/20
End: 09/08/23
Due: 09/08/24
Phase: N/A
Priority: Normal
Start: 04/02/23
End: 04/02/24
Due: 04/02/25
Phase: N/A
Priority: Normal
Start: 01/14/22
End: 11/14/24
Due: 11/14/25
Phase: N/A
Priority: Normal
Start: 10/04/23
End: 04/19/27
Due: 04/19/28
Phase: N/A
Priority: Normal
Start: 02/05/19
End: 01/25/24
Due: 01/25/25